BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9076910)

  • 1. Complications and concurrent disease associated with canine hyperadrenocorticism.
    Nichols R
    Vet Clin North Am Small Anim Pract; 1997 Mar; 27(2):309-20. PubMed ID: 9076910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of pituitary-dependent hyperadrenocorticism. Mitotane.
    Peterson ME; Kintzer PP
    Vet Clin North Am Small Anim Pract; 1997 Mar; 27(2):255-72. PubMed ID: 9076906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent illness and complications associated with canine hyperadrenocorticism.
    Nichols R
    Probl Vet Med; 1990 Dec; 2(4):565-72. PubMed ID: 2134075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus, hyperadrenocorticism, and hypothyroidism in a dog.
    Hess RS; Ward CR
    J Am Anim Hosp Assoc; 1998; 34(3):204-7. PubMed ID: 9590447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems associated with medical therapy of canine hyperadrenocorticism.
    Nichols R
    Probl Vet Med; 1990 Dec; 2(4):551-6. PubMed ID: 2134073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of renal vascular resistance in dogs with diabetes mellitus and hyperadrenocorticism.
    Novellas R; de Gopegui RR; Espada Y
    Vet Rec; 2008 Nov; 163(20):592-6. PubMed ID: 19011245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of canine pituitary-dependent hyperadrenocorticism with l-deprenyl (Anipryl).
    Bruyette DS; Ruehl WW; Entriken T; Griffin D; Darling L
    Vet Clin North Am Small Anim Pract; 1997 Mar; 27(2):273-86. PubMed ID: 9076907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
    Feldman EC; Nelson RW; Feldman MS; Farver TB
    J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent illness and complications associated with canine hyperadrenocorticism.
    Nichols R
    Semin Vet Med Surg Small Anim; 1994 Aug; 9(3):132-6. PubMed ID: 7938932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitotane (o,p'-DDD) resistance in a dog with pituitary-dependent hyperadrenocorticism and phaeochromocytoma.
    Bennett PF; Norman EJ
    Aust Vet J; 1998 Feb; 76(2):101-3. PubMed ID: 9578778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperadrenocorticism: treating dogs.
    Brown CG; Graves TK
    Compend Contin Educ Vet; 2007 Mar; 29(3):132-4, 136, 138 passim; quiz 144-5. PubMed ID: 17726933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Hypertriglyceridemia as a Mediator Between Endocrine Diseases and Pancreatitis in Dogs.
    Kim H; Kang JH; Heo TY; Kang BT; Kim G; Chang D; Na KJ; Yang MP
    J Am Anim Hosp Assoc; 2019; 55(2):92-100. PubMed ID: 30776262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotane (o,p'-DDD) treatment in a cat with hyperadrenocorticism.
    Schwedes CS
    J Small Anim Pract; 1997 Nov; 38(11):520-4. PubMed ID: 9403812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane.
    Reine NJ
    Clin Tech Small Anim Pract; 2007 Feb; 22(1):18-25. PubMed ID: 17542193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
    Angles JM; Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1997 Oct; 211(8):1002-4. PubMed ID: 9343543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperadrenocorticism associated with excessive sex hormone production by an adrenocortical tumor in two dogs.
    Syme HM; Scott-Moncrieff JC; Treadwell NG; Thompson MF; Snyder PW; White MR; Oliver JW
    J Am Vet Med Assoc; 2001 Dec; 219(12):1725-8, 1707-8. PubMed ID: 11767922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Formal pathogenesis, average age and breed distribution in the comparison of 61 Lysodren-treated and 36 untreated cases of canine hyperadrenocorticism which were dissected in the years 1975 to 1991 at the Institute for Veterinary Pathology of the Free University of Berlin].
    Nothelfer HB; Weinhold K
    Berl Munch Tierarztl Wochenschr; 1992 Sep; 105(9):305-11. PubMed ID: 1417721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perianal adenomas and hypertestosteronemia in a spayed bitch with pituitary-dependent hyperadrenocorticism.
    Dow SW; Olson PN; Rosychuk RA; Withrow SJ
    J Am Vet Med Assoc; 1988 May; 192(10):1439-41. PubMed ID: 2839445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alternative protocol for the medical management of canine pituitary-dependent hyperadrenocorticism.
    Rijnberk A; Belshaw BE
    Vet Rec; 1988 May; 122(20):486-8. PubMed ID: 3420770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic arterial blood pressure and urine protein/creatinine ratio in dogs with hyperadrenocorticism.
    Ortega TM; Feldman EC; Nelson RW; Willits N; Cowgill LD
    J Am Vet Med Assoc; 1996 Nov; 209(10):1724-9. PubMed ID: 8921029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.